Insider Trading & Executive Data
Start Free Trial
15 insider trades in the last year. Go beyond summary counts with transaction-level detail, compensation intelligence, and institutional ownership context.
FutureFuel Corp. is a vertically integrated specialty chemicals and biofuels manufacturer operating principally from a single, large Batesville, Arkansas site that supports continuous biodiesel production (~59 MMgy capacity; 45 MMgy produced in 2024) and batch custom chemical manufacturing. The business is two-segmented: biofuels (≈67% of 2024 revenue) and chemicals (custom specialty and performance chemicals ≈33%), with meaningful RIN generation and glycerin co‑product sales. Management emphasizes operational automation, ISO/GMP accreditations and ~$4.0M of annual R&D to move into higher‑value pharmaceutical intermediates, but the company is highly exposed to feedstock pricing, seasonality, RIN/CFPC policy outcomes and environmental/regulatory compliance. Recent performance has deteriorated materially (2024 revenue –34%; Q2 2025 YTD revenue down ~59%) driven mainly by lower biodiesel throughput, weaker RIN/biodiesel pricing and extended turnarounds.
Given FutureFuel’s operating profile and management commentary, short‑term incentives are likely tied to operational and commodity‑sensitive metrics (adjusted EBITDA, production uptime/throughput, LIFO/derivative‑adjusted margins) rather than solely GAAP earnings, since management explicitly emphasizes adjusted EBITDA to reflect operating performance. Long‑term incentives are likely structured to align executives with multi‑year capital projects, capacity reliability, and R&D commercialization (e.g., time‑vested and performance equity tied to capacity utilization, safety/environmental compliance, and strategic customer retention). Compensation plans in the Basic Materials / Specialty Chemicals sector commonly include cash bonuses for annual financial/operational targets, stock awards to retain key technical managers (chemists/engineers), and clawbacks or forfeiture provisions tied to regulatory violations or restatement risk given significant environmental liabilities. Because the business is cyclical and policy‑sensitive, boards often weight pay toward retention and long‑term performance metrics to dampen incentives to chase short‑term RIN or commodity swings.
Insiders at FutureFuel will likely trade around discrete, policy‑driven catalysts (EPA/RFS/CFPC announcements, CFPC implementation guidance, federal/state tax credit changes) and operational events (plant turnarounds, production idling/restarts, major customer wins or contract changes) that materially shift RIN economics and biodiesel margins. The company’s reliance on derivative hedges and LIFO accounting creates earnings volatility and potential surprise adjustments that can precede Form 4 activity; monitor for clustered sales after dividend declarations (notably the $2.50 special dividend in 2024) or before/after public disclosures of turnarounds or regulatory comment filings. Given concentrated counterparty exposure in biofuels and the cyclical cash profile, insider purchases can be a stronger signal of management conviction than routine sales, while insider sales clustered before negative operational disclosures may warrant closer scrutiny. Watch for 10b5‑1 plan filings, blackout periods around quarter‑end turnarounds, and disclosures tied to environmental liabilities (CERCLA/RCRA/TSCA) or major RIN/CFPC policy shifts.